Search
COPD Paid Clinical Trials in California
A listing of 16 COPD clinical trials in California actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 16 of 16
The state of California currently has 16 active clinical trials seeking participants for COPD research studies. These trials are conducted in various cities, including Los Angeles, San Francisco, San Diego and Sacramento.
Featured Trial
Chronic Obstructive Pulmonary Disease Study
Recruiting
Conditions:
Lung Disease (COPD)
Smoker
Featured Trial
COPD Study
Recruiting
Featured Trial
Chronic obstructive pulmonary disease (COPD) Trials
Recruiting
Chronic obstructive pulmonary disease (COPD) trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Chronic obstructive pulmonary disease (COPD)
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Chronic Cough Clinical Study
Recruiting
We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Conditions:
Cough
Chronic Cough
Asthma
Allergic Asthma
Sinusitis
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Revefenacin in Acute Respiratory Insufficiency in COPD
Recruiting
RARICO is a pragmatic, randomized, controlled, double-blinded, multi-center trial evaluating the safety and feasibility of nebulized revefenacin in comparison to nebulized ipratropium in patients with COPD and acute respiratory failure requiring invasive mechanical ventilation.
Gender:
All
Ages:
40 years and above
Trial Updated:
12/01/2023
Locations: Ronald Reagan Medical Center at UCLA, Los Angeles, California +1 locations
Conditions: COPD, Acute Respiratory Failure
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
Recruiting
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarinic receptor antagonists, inhaled and or oral corticosteroid, oral antibiotic, supplemental oxygen, and... Read More
Gender:
All
Ages:
30 years and above
Trial Updated:
10/25/2023
Locations: Arthur F Gelb MD, Lakewood, California +1 locations
Conditions: COPD, Emphysema, Asthma COPD Overlap, Emphysema
Pulmonary Specialist-Health Coach Consult Model Study
Recruiting
The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap syndrome (ACOS) for low-income and vulnerable patients seen at public health clinics. Three hundred sixty (360) patients from ten clinics will be enrolled in the study and randomized at the individual level to receive health... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/21/2023
Locations: St. Anthony Medical Clinic, San Francisco, California +10 locations
Conditions: COPD Asthma
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
Recruiting
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD is unclear, but understanding its underlying biology has important implications for our ability to design suitable preventative and therapeutic strategies for its management. This Department of Defense (DOD) discovery research proposes to develop methodologies and generate preliminary data needed to lay t... Read More
Gender:
All
Ages:
Between 40 years and 75 years
Trial Updated:
06/06/2022
Locations: Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California +2 locations
Conditions: Copd, Smoking, Tobacco Use
13 - 16 of 16